Product image of Molaxole (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350) supplied by GNH India

Molaxole

Active Ingredient:
Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350
Origin:
EU

Molaxole (Sodium Hydrogen Carbonate, Potassium Chloride, Sodium Chloride, Macrogol 3350)

Macrogol 3350, the active ingredient in Molaxole, is an osmotic laxative presented as an oral powder for oral use. It works together with sodium hydrogen carbonate, potassium chloride and sodium chloride to relieve constipation and to prepare the bowel for diagnostic procedures in adults and children.
GNH India supplies Molaxole as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Mylan Healthcare B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Molaxole is an oral osmotic laxative used in conditions that require stool softening or bowel cleansing.

  • Constipation: softens stool and increases bowel frequency through osmotic water retention.
  • Bowel preparation for colonoscopy: facilitates thorough cleansing of the colon before endoscopic examination.
  • Irritable bowel syndrome with constipation: helps regulate bowel movements and reduce discomfort.

How It Works

  • Macrogol 3350 is a high‑molecular‑weight polyethylene glycol that is poorly absorbed in the gastrointestinal tract. It retains water in the intestinal lumen by creating an osmotic gradient, increasing stool volume and softness. The accompanying electrolytes (sodium hydrogen carbonate, potassium chloride, sodium chloride) help maintain electrolyte balance while the osmotic effect promotes peristalsis and facilitates bowel evacuation.

Side Effects

Molaxole may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

  • Nausea: mild stomach upset after ingestion.
  • Abdominal bloating: sensation of fullness due to retained fluid.
  • Flatulence: increased intestinal gas production.
  • Diarrhea: loose stools if the dose is higher than needed.
  • Mild electrolyte disturbance: slight changes in sodium or potassium levels.

Serious or Rare Side Effects

  • Severe dehydration: excessive fluid loss leading to low blood pressure.
  • Significant electrolyte imbalance: marked hyponatremia or hyperkalemia.
  • Allergic reaction: rash, itching, or swelling of the face and throat.
  • Severe abdominal pain: persistent or worsening pain requiring medical evaluation.
  • Colonic perforation: extremely rare but serious intestinal injury.

Precautions & Warnings

Before using Molaxole, consider the following safety measures.

  • Renal function assessment: evaluate kidney status to avoid fluid overload.
  • Electrolyte monitoring: check serum sodium and potassium especially in long‑term use.
  • Bowel obstruction: avoid in patients with known mechanical obstruction.
  • Hypersensitivity: discontinue if allergic reactions occur.
  • Duration of therapy: limit use to the shortest effective period.
  • Store at ambient temperature: keep in the original pack, protect from moisture.

Avoid Interactions

Molaxole can interact with other medicines that affect fluid or electrolyte balance.

Major Interactions (Avoid)

  • Concomitant osmotic laxatives: risk of severe dehydration and electrolyte loss.
  • Loop diuretics: may exacerbate potassium depletion.
  • ACE inhibitors or ARBs: potential for additive hyperkalemia.
  • NSAIDs: increased risk of renal impairment.

Moderate Interactions (Monitor Closely)

  • Anticholinergic agents: may reduce laxative efficacy.
  • Calcium or magnesium supplements: could alter electrolyte profile.
  • Oral rehydration solutions: monitor total fluid intake to prevent overload.

Frequently Asked Questions

Molaxole is an oral powder that combines macrogol 3350 with electrolytes to treat constipation and to cleanse the bowel before diagnostic procedures such as colonoscopy. It works by drawing water into the intestinal lumen, softening stool and promoting evacuation.

Macrogol 3350 is a high‑molecular‑weight polyethylene glycol that is minimally absorbed. It creates an osmotic gradient that retains water in the gut, increasing stool volume and softness. The added electrolytes help maintain normal sodium, potassium and chloride levels while the osmotic effect stimulates peristalsis.

The dose of Molaxole is individualized by the prescribing healthcare professional based on the patient’s age, condition and response. The prescriber determines the amount of powder to dissolve in water and the frequency of administration.

Safety of Molaxole in pregnancy or while breastfeeding has not been fully established. Healthcare providers should weigh the potential benefits against possible risks and consider alternative treatments if appropriate.

To order Molaxole, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Compared with stimulant laxatives, Molaxole’s macrogol 3350 provides an osmotic mechanism that is generally gentler on the colon and less likely to cause cramping. Unlike simple saline laxatives, the formulation includes electrolytes to help maintain fluid balance during treatment.

Molaxole should be stored at ambient temperature, below 25 °C, in its original container. Keep the product away from moisture and direct sunlight to preserve its stability and effectiveness.

Molaxole is taken orally. The powder is dissolved in a specified amount of water, as instructed by the prescriber, and the solution is consumed. It can be taken with or without food, but adequate fluid intake throughout the day is recommended.

Serious risks include severe dehydration, significant electrolyte disturbances (such as hyponatremia or hyperkalemia), allergic reactions, and, rarely, colonic perforation. Patients should seek medical attention if they experience extreme weakness, rapid heartbeat, severe abdominal pain or signs of an allergic response.

Molaxole should be avoided in individuals with known hypersensitivity to any component, those with mechanical bowel obstruction, severe renal impairment, or uncontrolled electrolyte disorders. It is also contraindicated in patients who have recently undergone intestinal surgery without medical guidance.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.